Dr Malcolm Berry
Malcolm trained as a chemist, obtaining a PhD from Imperial College in 1993. Started work at GlaxoGroupResearch the year. In 2000 he volunteered to lead a team that developed the equipment and thinking behind continuous manufacturing for API’s at GSK. This led to filing the first multistage process in pharma being filed for an API in 2018; approved in 2019.
Malcolm left GSK in Oct 2019 to start a consultancy practise, advising companies how to develop and implement continuous processes.